Topic

Firdapse (amifampridine)

A collection of 27 issues

How to Get Firdapse (amifampridine) Covered by Blue Cross Blue Shield in Washington: Complete Prior Authorization and Appeals Guide

Answer Box: Getting Firdapse Covered by Blue Cross Blue Shield in Washington Firdapse (amifampridine) requires prior authorization from Blue Cross Blue Shield plans in Washington for Lambert-Eaton myasthenic syndrome (LEMS). To get approval: (1) Ensure confirmed LEMS diagnosis with EMG and anti-VGCC antibodies by a neuromuscular specialist, (2) Submit PA
6 min read

Getting Firdapse (Amifampridine) Covered by Humana in Florida: PA Requirements, Appeals Timeline, and Cost Support

Quick Answer: Humana requires prior authorization for Firdapse (amifampridine) to treat Lambert-Eaton myasthenic syndrome (LEMS). You'll need confirmed LEMS diagnosis via antibody testing and EMG, neuromuscular specialist documentation, and evidence of medical necessity. If denied, file a redetermination appeal within 65 days. Start today: Call Humana member services
5 min read

How to Get Firdapse (Amifampridine) Covered by UnitedHealthcare in Texas: Appeals Process, Forms, and Approval Scripts

Answer Box: Getting Firdapse Covered by UnitedHealthcare in Texas UnitedHealthcare requires prior authorization for Firdapse (amifampridine) in Texas with no step therapy requirement. Submit via the UHC Provider Portal with confirmed LEMS diagnosis (P/Q-type VGCC antibodies + EMG showing ≥60% CMAP increment), neurologist prescription, and no seizure history. Standard approval
5 min read

UnitedHealthcare's Coverage Criteria for Firdapse (amifampridine) in New Jersey: What Counts as "Medically Necessary"?

Answer Box: Getting Firdapse Approved by UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Firdapse (amifampridine) through OptumRx with confirmed LEMS diagnosis by a neurologist, diagnostic testing (EMG and VGCC antibodies), and no seizure history. No step therapy is required. If denied, you have 60 days to appeal internally,
6 min read